Location: Munich, Germany
Date: August 25 to July 29
European Society of Cardiology Congress
What is the importance of the new ESH/ESC hypertension guideline?
Stroke, atrial fibrillation and NOACs
CV event prevention in type-2 diabetes
How to use the free UK Biobank for cardiac research?
Residual CV risk in post-MI patients
What’s new in the 2018 ESH/ESC Hypertension guideline?
How to prevent major cardiovascular complications in type-2 diabetes?
COMPASS trial update at ESC2018
MANAGE and RE-DUAL trial updates at ESC2018
New ESC/ESC hypertension guideline
How much did heart surgery develop in last years?
Coronary risk and risk stratification
How to reduce premature cardiovascular mortality in type-2 diabetes?
How to assess NOAC anticoagulant activity in emergency situations?
EHRA practical guide for treatment of atrial fibrillation patients
How can we translate the new GLP-1 outcome trials into clinical practice?